Evrofarma SA (ATH:EVROF)
Greece · Delayed Price · Currency is EUR 3.660
-0.040 (-1.08%)
Jul 31, 2026, 4:50 PM EET
Evrofarma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.56 | 3.32 | 0.66 | 1.44 | 0.25 |
Cash & Short-Term Investments | 6.56 | 3.32 | 0.66 | 1.44 | 0.25 |
Cash Growth | 97.47% | 405.94% | -54.28% | 477.11% | -91.99% |
Receivables | 10.21 | 7.37 | 9.17 | 11.72 | 13.69 |
Inventory | 7.07 | 7.11 | 6.52 | 5.56 | 3.07 |
Other Current Assets | - | - | -0 | - | - |
Total Current Assets | 23.85 | 17.8 | 16.34 | 18.71 | 17.01 |
Property, Plant & Equipment | 26.02 | 24.87 | 25.57 | 24.95 | 24.41 |
Long-Term Investments | 0.01 | 0.01 | 0.01 | 0.06 | 0.04 |
Other Intangible Assets | 0.35 | 0.13 | 0.05 | 0.06 | 0.1 |
Long-Term Accounts Receivable | 0.33 | 0.03 | 0.33 | 0.03 | 0.03 |
Other Long-Term Assets | 5.8 | 5.4 | 5.06 | 5.01 | 4.94 |
Total Assets | 56.35 | 48.24 | 47.36 | 48.81 | 46.52 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.08 | 2.43 | 2.39 | 4.45 | 3.44 |
Accrued Expenses | 0.57 | 0.53 | 0.5 | 0.45 | 0.87 |
Short-Term Debt | - | 9.95 | 3.9 | 2.44 | 0.72 |
Current Portion of Long-Term Debt | 1.99 | 1.64 | 3.08 | 2.71 | 2.5 |
Current Portion of Leases | 0.06 | 0.07 | 0.04 | 0.04 | 0.03 |
Current Income Taxes Payable | 0.73 | 0.49 | 0.4 | 0.11 | - |
Other Current Liabilities | 3.26 | 3.17 | 2.73 | 2.48 | 2.64 |
Total Current Liabilities | 10.7 | 18.26 | 13.04 | 12.67 | 10.2 |
Long-Term Debt | 14.94 | 5.16 | 12.45 | 16.13 | 18.05 |
Long-Term Leases | 0.07 | 0.14 | 0.07 | 0.06 | 0.01 |
Long-Term Unearned Revenue | 8.78 | 5.73 | 4.43 | 4.69 | 4.42 |
Pension & Post-Retirement Benefits | 0.09 | 0.08 | 0.07 | 0.05 | 0.05 |
Long-Term Deferred Tax Liabilities | 1.11 | 1.04 | 1.08 | 1.18 | 1.18 |
Other Long-Term Liabilities | - | -0 | - | -0 | - |
Total Liabilities | 35.69 | 30.41 | 31.13 | 34.79 | 33.92 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.74 | 5.74 | 5.74 | 12.03 | 12.03 |
Additional Paid-In Capital | - | - | - | 0.94 | 0.94 |
Retained Earnings | 10.84 | 8.46 | 7.42 | -1.49 | -0.38 |
Treasury Stock | -0.01 | - | - | - | - |
Comprehensive Income & Other | 4.08 | 3.62 | 3.06 | 2.55 | 0.02 |
Shareholders' Equity | 20.66 | 17.83 | 16.23 | 14.03 | 12.61 |
Total Liabilities & Equity | 56.35 | 48.24 | 47.36 | 48.81 | 46.52 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.06 | 16.95 | 19.53 | 21.38 | 21.31 |
Net Cash (Debt) | -10.5 | -13.63 | -18.87 | -19.94 | -21.06 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.77 | -1.00 | -1.38 | -1.46 | -1.54 |
Filing Date Shares Outstanding | 13.67 | 13.67 | 13.67 | 13.67 | 13.67 |
Total Common Shares Outstanding | 13.67 | 13.67 | 13.67 | 13.67 | 13.67 |
Working Capital | 13.15 | -0.46 | 3.3 | 6.04 | 6.81 |
Book Value Per Share | 1.51 | 1.30 | 1.19 | 1.03 | 0.92 |
Tangible Book Value | 20.31 | 17.69 | 16.18 | 13.97 | 12.51 |
Tangible Book Value Per Share | 1.49 | 1.29 | 1.18 | 1.02 | 0.91 |